# CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer

> **NCT00129870** · PHASE4 · TERMINATED · sponsor: **Sanofi** · enrollment: 180 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT00129870
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 180 (ACTUAL)
- **Why stopped:** Unplanned interim analysis by DSMB indicated possible reduced response rate with the addition of Ca/Mg in pooled population. Further analysis pending.
- **Last updated:** 2009-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00129870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00129870, "CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00129870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*